Evonik’s Corporate Venture Capital unit with a fund size of €250 million and more than 30 investments since 2012. The investment scope ranges from early stage to growth stage with an investment volume of up to €15 million per portfolio company.
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Mentions in press and media 9
| Date | Title | Description |
| 18.02.2022 | Biograil Secures Seed 2 Funding for Oral Delivery Device for Biologics | February 17, 2022 |
| 22.12.2021 | UnionTech raises $31M in bid to take SLA 3D printing success to new heights | Industrial stereolithography (SLA) 3D printer manufacturer UnionTech has managed to secure $31 million in Series D funding, according to Pandaily sources. Led by Dening Capital, the investment is also said to have been backed by Cash Capita... |
| 03.04.2021 | Evonik Industries : Sustainability Report 2020 | SUSTAINABILITY REPORT Next Generation Solutions 2020 CONTENTS INTERACTIVE PDF Optimized for on-screen use with Adobe Acrobat. AT A GLANCE 3 VALUE CHAIN AND PRODUCTS 38SAFETY 90 Short profile of Evonik 3 Ten key messages on sustainability at... |
| 29.03.2021 | EXCLUSIVE: In Ovo raises funding & hits milestone 150,000 chicks hatched without culling | In Ovo, a Netherlands-based startup developing a ‘no-cull’ solution for the chicken egg industry, has raised “several million euros” in a funding round from existing investors VisVires New Protein (VVNP) and Evonik Venture Capital – the VC ... |
| 04.03.2021 | EVONIK INDUSTRIES AG Evonik Industries : Sustainability Report 2020 | SUSTAINABILITY REPORT Next Generation Solutions 2020 CONTENTS INTERACTIVE PDF Optimized for on-screen use with Adobe Acrobat. AT A GLANCE 3 VALUE CHAIN AND PRODUCTS 38SAFETY 90 Short profile of Evonik 3 Ten key messages on sustainability at... |
| 07.09.2016 | Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States | Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States Vivasure Medical™, a company developing a novel bioabsorbable technology for percutaneous vessel clos... |
| 31.03.2015 | Algal Scientific Scores $7M Series B, Expands in Animal Health | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Algal Scientific, a Plymouth, MI-based startup focused on developing algae-based chemicals to improve animal feed and human nutrition, announced this week that it has raised a... |
| 05.05.2014 | Algal Scientific’s Breakthrough Animal-Health Discoveries Draw Investor Interest | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Algal Scientific, a Northville, MI-based startup focused on improving animal feed and human nutrition as well as wastewater treatment, said last week that it has raised $3 mil... |
| - | Venture Capital: Evonik invests in SYNOSTE, a medical technology start-up in Düsseldorf and Helsinki | Evonik Industries has invested in the start-up company SYNOSTE Oy via its venture capital arm and now holds a minority share in the medical technology company based in Düsseldorf (Germany) and Helsinki (Finland). The investment was made as ... |